ClinicalTrials.govpublic full text
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
platinum-sensitive ovarian cancer, ovarian cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 911638
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.